![](https://endpts.com/wp-content/uploads/2023/11/GettyImages-1663517835-scaled.jpg)
Stéphane Bancel, Moderna CEO (Christopher Goodney/Bloomberg via Getty Images)
Moderna looks past post-Covid 'low point' at a future based on combination vaccines, cancer indications
The Covid boom is over at Moderna.
On Thursday, the biotech said it was bracing for sales to “hit a low point” in 2024 as …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.